share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Director SANSONE GUY P

CVS Health | 4: Statement of changes in beneficial ownership of securities-Director SANSONE GUY P

西維斯健康 | 4:持股變動聲明-董事 SANSONE GUY P
美股SEC公告 ·  11/25 17:12

Moomoo AI 已提取核心訊息

On 11/21/2024, Guy P Sansone completed the acquisition of 2,200 shares of CVS Health common stock. The transaction was executed at a price of $57.1 per share, resulting in a total transaction value of approximately $125,620. This acquisition was categorized as a grant, award, or other acquisition, and the shares are held directly by Sansone.Following this transaction, Sansone's total beneficial ownership of CVS Health shares increased to approximately 8,360 shares. The transaction was completed as per the reported details, with no shares disposed of during this period. This acquisition reflects a strategic move by Sansone, potentially indicating confidence in the company's future performance.
On 11/21/2024, Guy P Sansone completed the acquisition of 2,200 shares of CVS Health common stock. The transaction was executed at a price of $57.1 per share, resulting in a total transaction value of approximately $125,620. This acquisition was categorized as a grant, award, or other acquisition, and the shares are held directly by Sansone.Following this transaction, Sansone's total beneficial ownership of CVS Health shares increased to approximately 8,360 shares. The transaction was completed as per the reported details, with no shares disposed of during this period. This acquisition reflects a strategic move by Sansone, potentially indicating confidence in the company's future performance.
2024年11月21日,Guy P Sansone完成了對2,200股CVS Health普通股的收購。該交易以每股57.1美元的價格執行,總交易價值約爲125,620美元。此次收購被歸類爲贈款、獎勵或其他收購,股份由Sansone直接持有。在這筆交易之後,三松對CVS Health股票的總實益所有權增加到約8,360股。根據報告的細節,該交易已完成,在此期間沒有出售任何股份。此次收購反映了Sansone的戰略舉措,可能表明了對公司未來業績的信心。
2024年11月21日,Guy P Sansone完成了對2,200股CVS Health普通股的收購。該交易以每股57.1美元的價格執行,總交易價值約爲125,620美元。此次收購被歸類爲贈款、獎勵或其他收購,股份由Sansone直接持有。在這筆交易之後,三松對CVS Health股票的總實益所有權增加到約8,360股。根據報告的細節,該交易已完成,在此期間沒有出售任何股份。此次收購反映了Sansone的戰略舉措,可能表明了對公司未來業績的信心。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息